Kelly Doyle, PhD, DABCC, FAACC


  • English
  • Portuguese
  • Spanish

Academic Information

  • Departments: Pathology - Adjunct Assistant Professor
  • Divisions: Clinical Pathology

Board Certification

  • American Board of Clinical Chemistry

Academic Office Information

  • 801-585-6217
  • ARUP Laboratories
    500 S Chipeta Way
    Salt Lake City, UT 84108


Academic Bio

Dr. Kelly Doyle is a fellow in the National Academy of Clinical Biochemistry and is a board certified clinical chemist. His interests involve the clinical application and implementation of mass spectrometry, emerging biomarkers, toxicology, and laboratory best practice. He has a special interest in training clinical chemistry fellows and teaching principles of laboratory medicine to pathology residents and medical students.

Education History

Type School Degree
Fellowship University of Utah School of Medicine
Clinical Chemistry
Research Fellow Huntsman Cancer Institute, Center for Investigational Therapeutics
Postdoctoral Research Fellow
Doctoral Training University of Utah
Medicinal Chemistry
Undergraduate Utah State University

Selected Publications

Journal Article

  1. Natali R, Wand C, Doyle K, Noguez JH (2018 Mar). Evaluation of a new venous catheter blood draw device and its impact on specimen hemolysis rates. Practical Laboratory Medicine, 10, 38-43.
  2. Gupta S, Doyle K, Mosbruger TL, Butterfield A, Weston A, Ast A, Kaadige M, Verma A, Sharma S (2018 Feb 9). Reversible LSD1 inhibition with HCI-2509 induces the p53 gene expression signature and disrupts the MYCN signature in high-risk neuroblastoma cells. Oncotarget, 9(11), 9907-9924.
  3. Doyle K, Strathmann FG (2017 Feb 1). Cost and Efficacy Assessment of an Alternative Medication Compliance Urine Drug Testing Strategy. Pain Med, 18(2), 307-315.
  4. Marin SJ, Doyle K, Chang A, Concheiro-Guisan M, Huestis MA, Johnson-Davis KL (2016 Jan-Feb). One Hundred False-Positive Amphetamine Specimens Characterized by Liquid Chromatography Time-of-Flight Mass Spectrometry. J Anal Toxicol, 40(1), 37-42.
  5. Doyle K, Fitzpatrick FA (2010 Jun 4). Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class I histone deacetylases 1, 2, and 3 and antagonizes their transcriptional repressor function. J Biol Chem, 285(23), 17417-24.
  6. Cordray P, Doyle K, Edes K, Moos PJ, Fitzpatrick FA (2007 Nov 9). Oxidation of 2-Cys-peroxiredoxins by arachidonic acid peroxide metabolites of lipoxygenases and cyclooxygenase-2. J Biol Chem, 282(45), 32623-9.
  7. Allred RA, Doyle K, Arif AM, Berreau LM (2006 May 15). Solvent effects on the structural and formyl substrate reactivity properties of a nitrogen/sulfur-ligated zinc hydroxide complex. Inorg Chem, 45(10), 4097-108.
  8. Makowska-Grzyska MM, Doyle K, Allred RA, Arif AM, Berreau LM (). Structural, Spectroscopic, and Reactivity Properties of N2S2(thioether)O(amide)-Ligated Hg(II) Complexes: The First Examples of Hg(II)-Mediated Amide Cleavage. Eur J Inorg Chem, 2005(5), 822-7.


  1. Doyle K (). Parkin Function in Parkinson’s Disease. Clin Chem (64(11), p. 1676).